Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitrogen is a fundamental chemical element (atomic number 7) that predominantly exists as a diatomic gas (N2), making up approximately 78% of Earth's atmosphere [1]. While nitrogen atoms are essential building blocks for all proteins and nucleic acids in the human body, elemental nitrogen is biologically inert and is not recognized as a molecular drug target such as a receptor, enzyme, or transporter [2]. Clinically, its primary use is in the liquid state for cryotherapy (cryosurgery), where it serves as a cooling agent to induce localized tissue destruction (cryonecrosis) for the treatment of various skin pathologies and some internal tumors [3]. Beyond its use in cryosurgery, nitrogen gas can pose significant health risks in specialized environments, such as nitrogen narcosis in deep-sea diving or asphyxiation in low-oxygen settings [4]. Because it is a basic element and not a specific protein or signaling molecule, it does not fit the standard definition of a therapeutic target in drug development [1][2]. Sources: [1] PubChem, Compound Summary: Nitrogen (CID 5362570). [2] National Center for Biotechnology Information (NCBI), Biochemistry of Nitrogen and amino acids. [3] StatPearls, Cryosurgery (Liquid Nitrogen). [4] National Institutes of Health (NIH), Nitrogen Narcosis and Decompression Sickness.
Nitrogen itself does not have a molecular mechanism of action as a drug target. However, in cryotherapy, liquid nitrogen induces therapeutic cryonecrosis through the rapid freezing of intracellular and extracellular water, leading to cell membrane rupture, protein denaturation, and localized vascular stasis [3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrogen (N).